WuXi AppTec Co., Ltd. (SHA:603259)
China · Delayed Price · Currency is CNY 93.00
-3.27 (-3.40%)
Aug 1, 2025, 3:00 PM CST
Splunk Revenue
WuXi AppTec had revenue of 11.14B CNY in the quarter ending June 30, 2025, with 20.37% growth. This brings the company's revenue in the last twelve months to 41.48B, up 11.95% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
41.48B
Revenue Growth
+11.95%
P/S Ratio
6.38
Revenue / Employee
1.10M
Employees
39,414
Market Cap
264.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
| Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
| Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
| Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
| Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |
| Huadong Medicine | 42.23B |